Shares of vaccine companiesSLOTXOPfizer, Biotech and Moderna jumped on Friday. As scientists try to figure out how to deal with the new coronavirus which was first detected in South Africa.
On November 27, 2021, the Investors Business Daily website reported that Biontec said it would take two weeks for the company to determine whether the new strain of COVID-19, B.1.1.529, was B.1.1.529, or B.1.1.529. No, announced by the World Health Organization (WHO) as "Omicron" and nominated. worrisome mutation This is because it has a different mutation pattern than other species.
Biotech said, if needed, the company could improve its vaccine to fight omicron in six weeks.
r0;The company is slowly awaiting additional data from scientific testing in the next two weeks,r1; Biontech spokesman Charlotte Spitz said by email. Biotech will be able to determine whether B.1.1.529 can evade vaccines. which may force companies Improve the vaccine if it spreads around the world.r1;
Vaccine stock jumps for COVID-19 new species
Check the movements in the stock market. Shares of biotech vaccine maker Pfizer were up 14.2 percent at $348. Pfizer was up 6.1 percent at $54 and Moderna was up 20.6 percent at $329.63. Newly licensed Novavax in Indonesia. and the Philippines, up 9 percent at $217.97.
Representatives for Modernna and Pfizer did not comment on the matter, while Novavax spokesman Amy Speke said the company had begun developing a new vaccine based on the novel coronavirus gene. Most of them are new species.
r0;Novawax will be ready for testing and production in the coming weeks,r1; she said. r0;We will continue to work urgently to combat COVID-19. new species and the continued evolution of the coronavirus.r1;
Portal
